536 related articles for article (PubMed ID: 16892081)
21. No evidence for promoter region methylation of the succinate dehydrogenase and fumarate hydratase tumour suppressor genes in breast cancer.
Huang KT; Dobrovic A; Fox SB
BMC Res Notes; 2009 Sep; 2():194. PubMed ID: 19778456
[TBL] [Abstract][Full Text] [Related]
22. Redox stress is not essential for the pseudo-hypoxic phenotype of succinate dehydrogenase deficient cells.
Selak MA; Durán RV; Gottlieb E
Biochim Biophys Acta; 2006; 1757(5-6):567-72. PubMed ID: 16797480
[TBL] [Abstract][Full Text] [Related]
23. Biochemical assays for mitochondrial activity: assays of TCA cycle enzymes and PDHc.
Reisch AS; Elpeleg O
Methods Cell Biol; 2007; 80():199-222. PubMed ID: 17445696
[No Abstract] [Full Text] [Related]
24. Prolyl hydroxylases as regulators of cell metabolism.
Boulahbel H; Durán RV; Gottlieb E
Biochem Soc Trans; 2009 Feb; 37(Pt 1):291-4. PubMed ID: 19143649
[TBL] [Abstract][Full Text] [Related]
25. Mitochondrial metabolic remodeling in response to genetic and environmental perturbations.
Hollinshead KE; Tennant DA
Wiley Interdiscip Rev Syst Biol Med; 2016 Jul; 8(4):272-85. PubMed ID: 27196610
[TBL] [Abstract][Full Text] [Related]
26. Overview of mitochondrial germline variants and mutations in human disease: Focus on breast cancer (Review).
Jiménez-Morales S; Pérez-Amado CJ; Langley E; Hidalgo-Miranda A
Int J Oncol; 2018 Sep; 53(3):923-936. PubMed ID: 30015870
[TBL] [Abstract][Full Text] [Related]
27. Fumarase: a mitochondrial metabolic enzyme and a cytosolic/nuclear component of the DNA damage response.
Yogev O; Yogev O; Singer E; Shaulian E; Goldberg M; Fox TD; Pines O
PLoS Biol; 2010 Mar; 8(3):e1000328. PubMed ID: 20231875
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of SRF-FOS-JUNB pathway in fumarate hydratase deficiency and in uterine leiomyomas.
Raimundo N; Vanharanta S; Aaltonen LA; Hovatta I; Suomalainen A
Oncogene; 2009 Mar; 28(9):1261-73. PubMed ID: 19151755
[TBL] [Abstract][Full Text] [Related]
29. Succinate oxidase and fumarate reductase systems of filarial parasite Setaria digitata.
Unnikrishnan LS; Raj RK
Indian J Biochem Biophys; 2000 Apr; 37(2):130-4. PubMed ID: 10983424
[TBL] [Abstract][Full Text] [Related]
30. Multiple cutaneous and uterine leiomyomata resulting from missense mutations in the fumarate hydratase gene.
Chuang GS; Martinez-Mir A; Engler DE; Gmyrek RF; Zlotogorski A; Christiano AM
Clin Exp Dermatol; 2006 Jan; 31(1):118-21. PubMed ID: 16309500
[TBL] [Abstract][Full Text] [Related]
31. Exposure to high levels of fumarate and succinate leads to apoptotic cytotoxicity and altered global DNA methylation profiles in vitro.
Wentzel JF; Lewies A; Bronkhorst AJ; van Dyk E; du Plessis LH; Pretorius PJ
Biochimie; 2017 Apr; 135():28-34. PubMed ID: 28104508
[TBL] [Abstract][Full Text] [Related]
32. Uterine Leiomyomas with Specific Histology Features of Two Fumarate Hydratase/Succinate Dehydrogenase-Deficient Tumors: A Double Case Report.
Jovanović L; Milenković S; Andrić L; Stefanović R; Milošević B; Micić J; Pilić I; Beleslin A; Mihaljević O; Dokić M
Medicina (Kaunas); 2024 May; 60(5):. PubMed ID: 38793008
[No Abstract] [Full Text] [Related]
33. Fumarate hydratase deficiency and cancer: activation of hypoxia signaling?
Ratcliffe PJ
Cancer Cell; 2007 Apr; 11(4):303-5. PubMed ID: 17418405
[TBL] [Abstract][Full Text] [Related]
34. Mitochondria in cancer: not just innocent bystanders.
Frezza C; Gottlieb E
Semin Cancer Biol; 2009 Feb; 19(1):4-11. PubMed ID: 19101633
[TBL] [Abstract][Full Text] [Related]
35. No evidence for epigenetic inactivation of fumarate hydratase in leiomyomas and leiomyosarcomas.
Barker KT; Spendlove HE; Banu NS; Bridge JA; Fisher C; Shipley J; Garrett M; Manyonda I; Houlston RS
Cancer Lett; 2006 Apr; 235(1):136-40. PubMed ID: 15949892
[TBL] [Abstract][Full Text] [Related]
36. Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas.
Yoo A; Tang C; Zucker M; Fitzgerald K; DiNatale RG; Rappold PM; Weiss K; Freeman B; Lee CH; Schultz N; Motzer R; Russo P; Coleman J; Reuter VE; Chen YB; Carlo MI; Gill AJ; Kotecha RR; Ari Hakimi A; Reznik E
Eur Urol Focus; 2022 Sep; 8(5):1278-1288. PubMed ID: 35288096
[TBL] [Abstract][Full Text] [Related]
37. Targeted inactivation of fh1 causes proliferative renal cyst development and activation of the hypoxia pathway.
Pollard PJ; Spencer-Dene B; Shukla D; Howarth K; Nye E; El-Bahrawy M; Deheragoda M; Joannou M; McDonald S; Martin A; Igarashi P; Varsani-Brown S; Rosewell I; Poulsom R; Maxwell P; Stamp GW; Tomlinson IP
Cancer Cell; 2007 Apr; 11(4):311-9. PubMed ID: 17418408
[TBL] [Abstract][Full Text] [Related]
38. Genetically-defined metabolic reprogramming in cancer.
Mullen AR; DeBerardinis RJ
Trends Endocrinol Metab; 2012 Nov; 23(11):552-9. PubMed ID: 22858391
[TBL] [Abstract][Full Text] [Related]
39. Metabolic enzymes as oncogenes or tumor suppressors.
Thompson CB
N Engl J Med; 2009 Feb; 360(8):813-5. PubMed ID: 19228626
[No Abstract] [Full Text] [Related]
40. Oncometabolites in cancer aggressiveness and tumour repopulation.
Dando I; Pozza ED; Ambrosini G; Torrens-Mas M; Butera G; Mullappilly N; Pacchiana R; Palmieri M; Donadelli M
Biol Rev Camb Philos Soc; 2019 Aug; 94(4):1530-1546. PubMed ID: 30972955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
